Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Nymox Pharmaceutical Corp (NasdaqSC:NYMX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Insider
Location
9900 Cavendish Blvd., Quebec, H4M 2V2
St. Laurent, Canada
Phone: (514) 332-3222
Fax: (514) 332-2227
Email: info@nymox.com
Employees (last reported count): 45
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 68%
·Institutional: 0% (1% of float)
(8 institutions)
·Net Inst. Buying: 18.0K shares (+16.40%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Nymox Pharmaceutical Corporation is a development stage biopharmaceutical company. The Company specializes in the research and development of therapeutics and diagnostics for the aging population with an emphasis on Alzheimer's disease. The Company markets a proprietary diagnostic test for Alzheimer's disease, known as the AlzheimAlert Test, through its reference laboratory in Maywood, New Jersey. AlzheimAlert is an improved version of the Company's AD7C test, which has been on the market since 1997. AlzheimAlert is the latest generation of the Company's NTP testing technology. It measures the level of a brain protein called neural thread protein (NTP), which is elevated early in Alzheimer's disease as reported both in the scientific literature and at scientific conferences.
More from Market Guide: Expanded Business Description

Financial Summary
NYMX is a development stage biopharmaceutical company which specializes in the research and development of neurological therapeutics and diagnostics for the aging population, with emphasis on Alzheimer's disease. For the six months ended 6/30/01, total revenues totalled $229 thousand, up from $108 thousand. Net loss from U.S. GAAP decreased 35% to $1.3 million. Revenues reflect an increase in sales of diagnostic services. Lower loss reflects a decrease in salary expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Pay

W. David Angus, 62
Chairman
--  
Paul Averback, M.D., 49
Pres, CEO
$104K
Allan Reimer, Ph.D.
VP, Technology Acquisition and Devel.
--  
Roy Wolvin, 45
Sec., Treasurer, CFO
49K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:NYMXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 14-Dec-2000
$1.063
Recent Price$4.50 
52-Week High
on 14-Sep-2000
$6.063
Beta1.28 
Daily Volume (3-month avg)64.2K
Daily Volume (10-day avg)72.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change+27.4%
52-Week Change
relative to S&P500
+71.0%
Share-Related Items
Market Capitalization$98.1M
Shares Outstanding21.8M
Float7.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.12 
Earnings (ttm)-$0.17 
Earnings (mrq)-$0.03 
Sales (ttm)$0.02 
Cash (mrq)$0.02 
Valuation Ratios
Price/Book (mrq)36.45 
Price/EarningsN/A 
Price/Sales (ttm)277.00 
Income Statements
Sales (ttm)$348.0K
EBITDA (ttm)-$2.80M
Income available to common (ttm)-$3.53M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-78.20%
Return on Equity (ttm)-109.17%
Financial Strength
Current Ratio (mrq)0.89 
Debt/Equity (mrq)0.15 
Total Cash (mrq)$410.0K
Short Interest
As of 8-Aug-2001
Shares Short3,000 
Percent of Float0.0%
Shares Short
(Prior Month)
82.0K
Short Ratio0.04 
Daily Volume66.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.